Literature DB >> 30734517

A Prospective Assessment of an Adjustable, Immediate Fit, Transtibial Prosthesis.

Timothy Dillingham1, Jessica Kenia1, Frances Shofer2, Jim Marschalek3.   

Abstract

BACKGROUND: There exists a need for an adjustable socket to accommodate residual limb volume and shape changes. Further, limb loss rates globally are rising and there is a large unmet need for affordable and accessible prosthetic systems.
OBJECTIVE: To assess the utility of an immediate fit modular prosthetic system (iFIT Prosthetics, LLC).
DESIGN: Prospective feasibility study involving a 2-week single-group pre-post intervention study.
SETTING: Physical Medicine and Rehabilitation gait laboratory. PARTICIPANTS: Participants were at least 6 months post amputation and walking with a conventional prosthesis. They were free of skin wounds, other neurological disorders, and severe pain conditions.
METHODS: Participants were fit with an immediate fit prosthesis and instructed to wear it for a 2-week evaluation period. They were given a progressive wearing schedule and they completed outcome measurements at the 2-week follow-up. MAIN OUTCOME MEASUREMENTS: Self-reported satisfaction, gait biomechanics, and intrasocket peak pressures.
RESULTS: Twenty-six participants entered the study, with 22 completing the single group pre-post study. They averaged 50 years (SD ±10.2) of age; four were female. Sixteen were dysvascular and 10 were traumatic in etiology. Significant differences (P = .03) in self-reported satisfaction were found in favor of the iFIT device 29.33 (SD ± 4.51) versus the conventional device 25.52 (SD ± 6.8). No falls or limb ischemia were reported. Gait biomechanics revealed no differences across any temporal characteristics. Intrasocket peak pressures were significantly lower for the iFIT prostheses overall (P = .0014), at the anterior tibia (P = .0002), and the lateral side of the residual limb (P = .013).
CONCLUSIONS: The iFIT transtibial prosthetic system appears to be safe in this short-term single-group pre-post study. This study provided preliminary evidence to support the feasibility of the iFIT system. It compared favorably to participants' conventional prostheses across all outcome measures. With its cost, adjustability, and accessibility advantages, this device may prove useful for persons with transtibial amputations. A larger multicenter study is needed to confirm these results. LEVEL OF EVIDENCE: III.
© 2019 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2019        PMID: 30734517      PMCID: PMC9285654          DOI: 10.1002/pmrj.12133

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.218


  12 in total

Review 1.  Residual limb volume change: systematic review of measurement and management.

Authors:  Joan E Sanders; Stefania Fatone
Journal:  J Rehabil Res Dev       Date:  2011

2.  Use and satisfaction with prosthetic devices among persons with trauma-related amputations: a long-term outcome study.

Authors:  T R Dillingham; L E Pezzin; E J MacKenzie; A R Burgess
Journal:  Am J Phys Med Rehabil       Date:  2001-08       Impact factor: 2.159

3.  Phantom pain, residual limb pain, and back pain in amputees: results of a national survey.

Authors:  Patti L Ephraim; Stephen T Wegener; Ellen J MacKenzie; Timothy R Dillingham; Liliana E Pezzin
Journal:  Arch Phys Med Rehabil       Date:  2005-10       Impact factor: 3.966

4.  Dermatologic conditions associated with use of a lower-extremity prosthesis.

Authors:  Nancy L Dudek; Meridith B Marks; Shawn C Marshall; Jodi P Chardon
Journal:  Arch Phys Med Rehabil       Date:  2005-04       Impact factor: 3.966

5.  Prosthesis evaluation questionnaire for persons with lower limb amputations: assessing prosthesis-related quality of life.

Authors:  M W Legro; G D Reiber; D G Smith; M del Aguila; J Larsen; D Boone
Journal:  Arch Phys Med Rehabil       Date:  1998-08       Impact factor: 3.966

6.  Estimating the prevalence of limb loss in the United States: 2005 to 2050.

Authors:  Kathryn Ziegler-Graham; Ellen J MacKenzie; Patti L Ephraim; Thomas G Travison; Ron Brookmeyer
Journal:  Arch Phys Med Rehabil       Date:  2008-03       Impact factor: 3.966

7.  Biomechanical consequences of a tear of the posterior root of the medial meniscus. Similar to total meniscectomy.

Authors:  Robert Allaire; Muturi Muriuki; Lars Gilbertson; Christopher D Harner
Journal:  J Bone Joint Surg Am       Date:  2008-09       Impact factor: 5.284

8.  Limb amputation and limb deficiency: epidemiology and recent trends in the United States.

Authors:  Timothy R Dillingham; Liliana E Pezzin; Ellen J MacKenzie
Journal:  South Med J       Date:  2002-08       Impact factor: 0.954

9.  Femoral graft-tunnel angles in posterior cruciate ligament reconstruction: analysis with 3-dimensional models and cadaveric experiments.

Authors:  Sung-Jae Kim; Yong-Min Chun; Sung-Hwan Kim; Hong-Kyo Moon; Jae-Won Jang
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  The effects of suction and pin/lock suspension systems on transtibial amputees' gait performance.

Authors:  Hossein Gholizadeh; Noor Azuan Abu Osman; Arezoo Eshraghi; Sadeeq Ali
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  3 in total

1.  Improved Self-Reported Comfort, Stability, and Limb Temperature Regulation with an Immediate Fit, Adjustable Transtibial Prosthesis.

Authors:  Chloe McCloskey; Jessica Kenia; Frances Shofer; Jim Marschalek; Timothy Dillingham
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-11-02

2.  A Prospective Assessment of an Adjustable, Immediate Fit, Subischial Transfemoral Prosthesis.

Authors:  Timothy R Dillingham; Jessica L Kenia; Frances S Shofer; James S Marschalek
Journal:  Arch Rehabil Res Clin Transl       Date:  2022-05-02

3.  An Immediate Fit, Adjustable, Modular Prosthetic System for Addressing World-Wide Limb Loss Disability.

Authors:  Jessica Kenia; Bethany Wolf; Jim Marschalek; Timothy Dillingham
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.